People: Chemspec International Limited (CPC)

CPC on New York Consolidated

6.62USD
9 Feb 2010
Price Change (% chg)

$0.02 (+0.30%)
Prev Close
$6.62
Open
--
Day's High
$6.74
Day's Low
$6.59
Volume
28,922
Avg. Vol
17,574
52-wk High
$10.50
52-wk Low
$5.20

view people for:

Summary

Name Age Since Current Position
Yang, Jianhua 55 2006 Chairman of the Board, Chief Executive Officer
Zhu, Bing 44 2008 Chief Financial Officer
Tang, Yunhung 65 Executive Vice President - Marketing and Research and Development, Director
Shu, Peter 2009 Senior Vice President - Business Development
Yang, Xiaosong 36 2008 Vice President - Marketing
Yang, Wujun 57 2008 Vice President
Wang, Zixin 31 2008 Vice President
Yuan, Yunlong 35 2008 Vice President
Chen, Jinhua 2009 Vice President - Process Research and Development
Lu, Yuelie 2009 Vice President - Pharmaceutical Business Development
Sun, George 45 2008 Director
» Insider Trading

Biographies

Name Description
Yang, Jianhua Dr. Jianhua Yang, founder, has served as the Chairman of the board of directors and the Chief Executive Officer of Chemspec International Ltd. since its inception in 2006. Dr. Yang has been chairman and chief executive officer of Shanghai ChemSpec since he founded it in 1996. Dr. Yang has more than 20 years of experience in fluorinated specialty chemicals. Dr. Yang graduated from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences with a Ph.D. in science in 1988. In 1991, Dr. Yang was awarded with the National Natural Science Award (First Class) by the Chinese Academy of Sciences and in 1993, was awarded with the National Natural Science Award (Second Class) by the State Commission on Science and Technology of China.
Zhu, Bing Mr. Bing Zhu was appointed Chief Financial Officer of Chemspec International Ltd. in June 2008. Mr. Zhu will also become director upon the completion of offering. From May 2006 until June 2008, he was chief financial officer of Canadian Solar Inc., a Nasdaq-listed solar cell and module products manufacturer based in China. From March 2005 until May 2006, he was financial controller and acting chief financial officer of Canadian Solar Inc. Prior to that, Mr. Zhu was a commercial banking relationship account manager at Royal Bank of Canada. From May 1996 to June 2000, Mr. Zhu worked as the Shanghai chief representative of Raytheon Corporation and was in charge of market development for its commercial electronics, engineering & construction and commercial aircraft divisions in China. From 1993 to 1996, he was a corporate banking account manager for Banque Indosuez. His customers included the China operations of European- and North American- based multi-national companies as well as B- and H- share Chinese public companies. From 1986 to 1992, Mr. Zhu was an accountant and then a finance manager in a Chinese state-owned enterprise in Hangzhou, China. Mr. Zhu received his bachelor’s degree in business management in 1986 from Zhejiang University of Technology in China, and his MBA degree in 1993 from China Europe International Business School (previously known as China-Europe Management Institute).
Tang, Yunhung Dr. David Yunhung Tang was appointed as a member of board of directors of Chemspec International Ltd. in July 2008. Dr. Tang has worked for Shanghai ChemSpec as executive vice president of marketing and research and development since 2001. Dr. Tang is responsible for overseeing research and development and marketing activities. Dr. Tang has more than 30 years of experience in fluorinated specialty chemicals, having worked in a range of positions for Occidental Chemical Corporation, Buffalo, New York, from 1977 to 2000, including research scientist, technology group leader, technical manager, senior manager, general manager of a joint venture of Occidental Chemical Corporation and research fellow. In 1973, he obtained a Ph.D. from Indiana University, USA. In 1985, he obtained an MBA degree from the State University of New York at Buffalo, USA, and in 1987 he completed an executive management program at Northwestern University.
Shu, Peter Dr. Peter H. Shu is Senior Vice President - Business Development of Chemspec International Limited. Dr. Shu joins Chemspec with over 30 years of experience in marketing, sales, technology and management in multinational chemical companies in the United States, Hong Kong and Taipei. Most recently, Dr. Shu served as Global Marketing Manager in the Plastics Additives Business of Rohm and Haas, which is now a wholly owned subsidiary of the Dow Chemical Company. In this position, he directed a global strategic marketing and sales team. He also developed and implemented a global marketing and sales strategy. Prior to Rohm and Haas, Dr. Shu held a variety of roles with increasing responsibilities at Bayer AG from 1985 to 2005. He contributed significantly to the fast and profitable growth of various Bayer companies through his leadership in marketing and new business development, which included a number of strategic alliances and joint ventures. Dr. Shu holds a Ph.D. in Polymer Chemistry from Rensselaer Polytechnic Institute, an Master of Business Administration from the State University of New York at Albany, and a Bachelor of Science in Chemistry from National Taiwan University. Dr. Shu has nine patents and 17 publications.
Yang, Xiaosong Mr. Xiaosong Yang has been Vice President of Marketing of Chemspec International Ltd. since July 2008 and is responsible for overseeing marketing activities and has helped develop business with pharmaceutical customers. He joined Shanghai ChemSpec in May 2006. Mr. Yang has more than 10 years of experience in pharmaceutical operations. Mr. Yang received a bachelor of medicine in forensic medicine in 1996 from the Shanghai Medical University in China, and a master of science in information systems in 2003 from Northeastern University in the U.S. He is pursuing an EMBA degree from China Europe International Business School. Between 2003 and 2006, Mr. Yang was a general manager of the Business Department at Summit Pharmaceuticals (China) Ltd., responsible for new drug development projects and new business development for both the European and the US markets. Between 2002 and 2003, he was an independent contractor with CoreStreet, Ltd. Between 1996 and 2000, he worked in business development and sales at Sumitomo Corporation (Shanghai) Ltd.
Yang, Wujun Mr. Wujun Yang became Vice President of Chemspec International Ltd. in July 2008 and is responsible for overseeing the construction of facilities and purchase of raw materials. Mr. Yang has worked for Shanghai ChemSpec since 1997. Mr. Yang has more than 30 years of experience in the manufacturing of chemicals. Mr. Yang graduated from the Shanghai Institute of Chemistry and Technology, majoring in chemical engineering in 1977. Prior to joining the company, he served as an engineer with the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences from 1986 to 1996.
Wang, Zixin Mr. Zixin Wang has been Vice President of Chemspec International Ltd. since July 2008 and is responsible for administration and human resources. From 2006 to 2007, he was the financial controller of Shanghai ChemSpec. Prior to joining the company, he served as a project manager of Shanghai Boning Finance Advisory Limited, where he was responsible for advising on offshore initial public offerings of Chinese companies and investment activities in China of foreign companies. In 2004, he obtained his master’s degree in accounting from Shanghai Jiaotong University.
Yuan, Yunlong Mr. Yunlong Yuan has been Vice President of Chemspec International Ltd. since July 2008 and is responsible for overseeing manufacturing processes and operations. From 1998 to 2007, he was a director of research and development for Shanghai ChemSpec and was responsible for overseeing the research and development activities of Shanghai ChemSpec jointly with Dr. Tang. Mr. Yuan has more than 10 years of experience in fluorinated specialty chemicals. Mr. Yuan graduated from the chemistry department of East China University of Science and Technology majoring in industrial catalysis in 1996. Prior to joining the company company, he served as a technician with Nanjing Chemical Industrial (Group) Co., Ltd.
Chen, Jinhua Dr. Jinhua (Jim) Chen is Vice President - Process Research and Development of Chemspec International Limited. Previously the director of research and development at Chemspec, Dr. Chen will continue to oversee process research and development at Chemspec. Prior to joining Chemspec in June 2008, Dr. Chen was an associate research investigator in the global pharmaceutical research and development division at Abbott Laboratories in Chicago, Illinois. Dr. Chen was also an American Chemical Society Industrial Innovation Award winner and a member of the teams at Abbott Laboratories which launched the drugs Ritonavir and Lopinavir. He holds a Ph.D. in organometallic chemistry from the University of New Brunswick in Canada and a Bachelor of Science in organic chemistry from Xiamen University in the People's Republic of China.
Lu, Yuelie Dr. Yuelie Lu is Vice President - Pharmaceutical Business Development of Chemspec International Limited. Dr. Lu was recently hired as the vice president of pharmaceutical business development to oversee the expansion of business related to pharmaceutical chemicals and the operation of certified good manufacturing practices ("cGMP") facilities. Prior to joining Chemspec, Dr. Lu held a broad range of responsibilities at multiple pharmaceutical companies in the United States, with his two most recent positions being an associate director of chemical development at Lexicon Pharmaceuticals in New Jersey and a principle scientist at Amgen Inc. in California. Dr. Lu holds a Ph.D. from Purdue University and a Bachelor of Science from the University of Science & Technology of China.
Sun, George Dr. George Sun was appointed as a member of board of directors of Chemspec International Ltd. in July 2008. Dr. Sun currently serves as general manager of Omaha Capital China, a China-focused early growth and venture capital fund focusing on life sciences, clean technology and high technology. Previously, he spent more than 10 years at McKinsey & Company as a senior management consultant where he assisted companies in China in various industries on issues of strategy, organization and operations. Dr. Sun co-founded and served as the president of GanTech International Inc., a biopharmaceutical company. He also worked as a scientist at Rohm and Haas, a specialty chemicals company. Dr. Sun holds a Ph.D. in chemistry from California Institute of Technology, a M.S. in organic chemistry from Shanghai Institute of Organic Chemistry, and a B.S. in chemistry from University of Science and Technology of China. He also attended the advanced management program at the Wharton School, University of Pennsylvania.

Basic Compensation

Name Fiscal Year Total
Yang, Jianhua --
Zhu, Bing --
Tang, Yunhung --
Shu, Peter --
Yang, Xiaosong --
Yang, Wujun --
Wang, Zixin --
Yuan, Yunlong --
Chen, Jinhua --
Lu, Yuelie --
Sun, George --
As Of 

Options Compensation

Name Options Value
Yang, Jianhua 0 0
Zhu, Bing 0 0
Tang, Yunhung 0 0
Shu, Peter 0 0
Yang, Xiaosong 0 0
Yang, Wujun 0 0
Wang, Zixin 0 0
Yuan, Yunlong 0 0
Chen, Jinhua 0 0
Lu, Yuelie 0 0
Sun, George 0 0

Insider Trading

» Full list on Insider Trading
view people for: